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Introduction
At least two-thirds of cluster headache (CH) patients that
received the ATI Neurostimulation System have achieved
profound clinical improvements including acute headache
pain relief and/or significant attack frequency reduction.
The ATI Neurostimulator is inserted trans-orally using a
minimally invasive technique.
Aim
This analysis aims to characterize the long term safety
of the ATI Neurostimulation System in CH sufferers.
Method
Patients from the Pathway CH-1 and Pathway R-1 studies
were included in the analysis. All adverse events (AEs)
including transient swelling and pain, were documented
and assessed for relationship to procedure and/or the
presence of the neurostimulator.
Results
Ninety-eight (98) patients received the ATI Neurostimu-
lator as of May 2014. Fifteen patients (15%) reported no
AEs and 83 patients (85%) reported at least one related
AE. In total, 341 AEs were reported (average 4.1 AEs/
patient). Currently, 216 (63%) of all AEs have resolved;
average time to resolution was 69 days (range 0-611).
The majority of reported AEs (77.4%) occurred within
30 days of the insertion procedure (peri-op AEs). Of
these AEs, 82% of patients experienced sensory distur-
bances. The large majority (72%) of these events had a
mild to moderate impact on the patient’s daily activities
and were transient, with an average resolution of 110.3
days (range 20-313).
Conclusion
The majority of AEs were reported within 30 days of the
Neurostimulator insertion procedure and the majority
resolved within 3 months. These AEs are not different
from standard sequelae reported for other trans-oral
procedures and display a similar time course for healing.
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